DDW: Telaprevir Improves HCV Clearance in Resistant Patients (CM...

New Combo KOs HCV Without Interferon, Ribavirin...
(MedPage Today) -- A combination of direct-acting antiviral agents aimed at hepatitis C -- and given without standard therapy -- can lead to sustained virologic response in patients with a...

AASLD: Six Months of Novel Agent Works in Hep C...
BOSTON (MedPage Today) -- A shorter, six-month course of the investigational protease inhibitor boceprevir added to standard combination treatment appears just as effective as almost a full...

Novel HCV Drug Can Double Response Rate (CME/CE)
(MedPage Today) -- An investigational protease inhibitor aimed at blocking hepatitis C replication can double the response rate compared with standard care, researchers said.

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...